Palmitoylethanolamide and Metabolic Syndrome in Postmenopausal Women
Author Information
Author(s): Medoro Alessandro, Davinelli Sergio, Fogacci Federica, Alfieri Stefania, Tiso Domenico, Cicero Arrigo F. G., Scapagnini Giovanni
Primary Institution: Department of Medicine and Health Sciences “V.Tiberio”, University of Molise, Italy
Hypothesis
Can palmitoylethanolamide (PEA) help manage metabolic syndrome in postmenopausal women?
Conclusion
Palmitoylethanolamide may improve metabolic health and reduce symptoms associated with metabolic syndrome in postmenopausal women.
Supporting Evidence
- PEA activates PPAR-α, which is involved in lipid metabolism and inflammation.
- PEA may enhance energy expenditure and reduce fat accumulation.
- PEA has anti-inflammatory properties that could improve insulin sensitivity.
- PEA may help manage weight and appetite in postmenopausal women.
- PEA shows neuroprotective effects that could alleviate mood disturbances.
Takeaway
This study suggests that a natural substance called palmitoylethanolamide might help women after menopause stay healthy by improving their metabolism and reducing weight gain.
Methodology
This review summarizes existing evidence on the effects of palmitoylethanolamide on metabolic syndrome in postmenopausal women.
Limitations
Further large-scale clinical studies are needed to confirm the efficacy and safety of PEA.
Participant Demographics
Focus on postmenopausal women.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website